Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A New Generation Screening Collection (AXXDIV2.0) is Now Available for Drug Discovery Programs

Published: Thursday, September 26, 2013
Last Updated: Thursday, September 26, 2013
Bookmark and Share
Axxam S.p.A. announced that an entirely new generation screening collection is now available for drug discovery programs: AXXDIV2.0 made up with 240,000 carefully selected small molecules.

The selection of the compounds was carried out building on Axxam’s broad screening expertise and significant input was given by the Company’s team of medicinal and computational chemists to ensure that the identified screening hits may represent promising and favorable starting points for further optimization.

In order to meet the manifold needs of customers, the new screening collection AXXDIV2.0 includes three different subsets: Explorer Set (providing a scaffold based approach), Probe Set (ensuring highest chemical diversity), and Discovery Set (covering the fragment-like space). Enamine (www.enamine.net) was chosen as the compounds supplier having one of the world’s largest, most diverse and novel screening collection. Through Axxam`s partnership with Enamine, building blocks for all the compounds can be provided to allow significant speed up of the hit expansion and optimization processes.

Dr. Doris Hafenbradl, VP Discovery Services, Axxam, said: “Key for any successful hit discovery program is the quality of the compound library. That’s why we put a major effort into assembling this compound collection and applied the most stringent filters to favor lead-like properties. With this new collection we are addressing the needs of our clients to provide novel chemistry combined with a flexible model of generating custom subsets. The feedback from our customers has been extremely positive.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Axxam Awarded by Lombardy Region
Company awarded with EUR 0.5 million to support a innovative high throughput method for early “in vitro” safety risk assessment of compounds.
Saturday, October 29, 2011
Axxam SpA Receives Funding for the Development of Compounds for Prevention Treatment of Disability in MS
Axxam will screen its extensive chemical library to develop small molecules that target the sodium-calcium exchanger NCX1 on axons.
Wednesday, July 20, 2011
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Identified Compound Stops Cells Making Ribosomes
From study in yeast, researchers have identifed a compound that interferes with the assembly of ribosomes.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!